Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension
we received from Nicox SA and we took the liberty to publish the following press release: " Ocumension has submitted the New Drug Application (NDA) to the Chinese National Medical Products Administration (NMPA) for NCX 470 to lower intraocular pressure (IOP) in patients with open-angle glaucoma or…